Search
CLOSENewsroom
Newsroom
EATRIS-GR
Infrastructure for preclinical and early-phase clinical development of drugs, therapeutics and biomedical devicesNanoMito
Biological assessment of the toxicity of nanosystems in the nematode Caenorhabditis elegans and evaluation of their potential to extend healthspanThe National Hellenic Research Foundation participates in the funded European Project “Universal Platform Components for Safe Fair Interoperable Data Exchange, Monetisation and Trading” (Acronym: UPCAST), which provides a set of universal, trustworthy, transparent and user-friendly data market plugins for the automation of data sharing and processing agreements between businesses, public administrations and citizens.
The second Joint Action (JA) of the EU on Networks of Expertise on Cancer (JANE-2) was launched in Milan, Italy, on January 28-29, 2025. The project is a follow-up of the JA JANE (2022-2024) (https://jane-project.eu) and is coordinated by Italy through the Fondazione IRCCS Istituto Nazionale Tumori in Milan, involving 121 partners from 29 European countries and co-financed by the European Union (EU) with 40.5 million euros. Greece is represented in JANE-2 by the National Hellenic Research Foundation (NHRF) and the National and Kapodistrian University of Athens (NKUA) as participating institutions.
Organised in the context of the COST ACTION 2111-OneHealthdrugs – “One Health drugs against parasitic vector borne diseases in Europe and beyond” https://onehealthdrugs.com/.
The workshop seeks to provide up to date information and integration strategy on sustainable drug discovery for vector borne diseases (VBDs). Special emphasis will also be given to new targets for VBDs and methods to study their engagement as well as on biodegradability and toxicity aspects pinpointing the effect on the environment.
The event is open to PhD, young innovators and senior scientists from both academia and pharma.